NEW YORK (GenomeWeb News) – Biocius Life Sciences said that it has signed up Wako Pure Chemical Industries to distribute its mass spectrometry systems and services in Japan, under an agreement announced today.
Osaka-based Wako will be the exclusive distributor in Japan for the Biocius RapidFire label-free high-throughput systems and for the firm's portfolio of contract research offerings and services, including in vitro ADME screening applications, such as the recently launched RF300 system, Biocius said.
Wako's BioMedical Systems Department GM Haruki Oishi said in a statement that Biocius' tools and services "will enable us to provide our customers with drug discovery solutions" and with "a means to investigate therapeutics that have been difficult to analyze by conventional methods."
Wako will support the Biocius technology in Japan with application scientists and field support engineers.
Biocius was spun out of BioTrove late last year, following that firm's acquisition by Life Technologies.